Skip to main content
SpringerLink
Log in

Pembrolizumab

Autoimmune blistering disease, Grover-like lesions and dermal hypersensitivity reaction: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chen WS, et al. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. Journal of Cutaneous Pathology 45: 764-773, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1111/cup.13312 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pembrolizumab. Reactions Weekly 1736, 156 (2019). https://doi.org/10.1007/s40278-019-57049-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-57049-8

Search

Navigation